Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Molero

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Journal of Antimicrobial Chemotherapy|February 21, 2008
In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulationR Espada, S Valdespina, M A Dea, et al.
FEMS Microbiology Letters|July 31, 1999
Low virulence of a morphological Candida albicans mutantR Diez-Orejas, G Molero, I Ríos-Serrano, et al.
International Microbiology : the Official Journal of the Spanish Society for Microbiology|December 8, 2000
Candida albicans: genetics, dimorphism and pathogenicityG Molero, R Díez-Orejas, F Navarro-García, et al.
Journal of Bacteriology|May 13, 1999
Role of the mitogen-activated protein kinase Hog1p in morphogenesis and virulence of Candida albicansR Alonso-Monge, F Navarro-García, G Molero, et al.
Scandinavian Journal of Immunology|September 24, 2005
The importance of the phagocytes' innate response in resolution of the infection induced by a low virulent Candida albicans mutantG Molero, M V Guillén, L Martínez-Solano, et al.
Journal of Proteomics|March 24, 2021
A wide-ranging Pseudomonas aeruginosa PeptideAtlas build: A useful proteomic resource for a versatile pathogenJ A Reales-Calderón, Z Sun, V Mascaraque, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Antimicrobial Chemotherapy|February 21, 2008
In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulationR Espada, S Valdespina, M A Dea, et al.
FEMS Microbiology Letters|July 31, 1999
Low virulence of a morphological Candida albicans mutantR Diez-Orejas, G Molero, I Ríos-Serrano, et al.
International Microbiology : the Official Journal of the Spanish Society for Microbiology|December 8, 2000
Candida albicans: genetics, dimorphism and pathogenicityG Molero, R Díez-Orejas, F Navarro-García, et al.
Journal of Bacteriology|May 13, 1999
Role of the mitogen-activated protein kinase Hog1p in morphogenesis and virulence of Candida albicansR Alonso-Monge, F Navarro-García, G Molero, et al.
Scandinavian Journal of Immunology|September 24, 2005
The importance of the phagocytes' innate response in resolution of the infection induced by a low virulent Candida albicans mutantG Molero, M V Guillén, L Martínez-Solano, et al.
Journal of Proteomics|March 24, 2021
A wide-ranging Pseudomonas aeruginosa PeptideAtlas build: A useful proteomic resource for a versatile pathogenJ A Reales-Calderón, Z Sun, V Mascaraque, et al.
Pageof 2